Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Trajan Group Holdings Ltd ( (AU:TRJ) ) has shared an update.
Trajan Group Holdings Ltd has announced the issuance of 162,026 ordinary fully paid shares without disclosure under Part 6D.2 of the Corporations Act. The company has complied with relevant provisions of the Corporations Act and confirmed there is no excluded information required to be disclosed. This issuance is part of Trajan’s ongoing efforts to support its growth and operations in the analytical and life sciences industry.
The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.25 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
More about Trajan Group Holdings Ltd
Trajan Group Holdings Ltd is a global developer and manufacturer of analytical and life sciences products and devices. The company focuses on enabling science that benefits personal health through scientific tools and solutions, with applications in the analysis of biological, food, and environmental samples. Trajan supports the shift towards decentralized, personalized data-based healthcare and operates with over 600 employees across manufacturing sites in the US, Australia, Europe, and Malaysia.
Average Trading Volume: 38,885
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$121.9M
Find detailed analytics on TRJ stock on TipRanks’ Stock Analysis page.